Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
190M
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
38.3M
-
Shares change
-
+2.19M
-
Total reported value, excl. options
-
$215M
-
Value change
-
+$1.5M
-
Put/Call ratio
-
0.58
-
Number of buys
-
46
-
Number of sells
-
-54
-
Price
-
$5.61
Significant Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q1 2021
138 filings reported holding WVE - Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share as of Q1 2021.
Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.3M shares
of 190M outstanding shares and own 20.15% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7.78M shares), PRIMECAP MANAGEMENT CO/CA/ (4.67M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.5M shares), MAVERICK CAPITAL LTD (3.08M shares), BlackRock Inc. (2.98M shares), Nantahala Capital Management, LLC (2.88M shares), Bellevue Group AG (2.6M shares), JPMORGAN CHASE & CO (1.29M shares), D. E. Shaw & Co., Inc. (1.26M shares), and Point72 Asset Management, L.P. (849K shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.